ECLLA is proud to announce that it has joined the European Hematology Association (EHA) Patient Advocacy Committee (PAC) ahead of the EHA 2026 Congress. The EHA PAC plays an important role in ensuring that patient voices are represented within EHA activities, scientific discussions, education, and European policy engagement. The Committee brings together European and international patient organisations to strengthen collaboration between patient advocates, clinicians, researchers, and healthcare stakeholders across hematology.
Joining the EHA PAC represents an important milestone for ECLLA and reflects the organisation’s growing engagement within the European hematology community. Through participation in the Committee, ECLLA looks forward to contributing to collaborative discussions focused on advocacy, education, awareness, equitable access to care, and improving outcomes for people living with Chronic Lymphocytic Leukemia (CLL) across Europe.
ECLLA also looks forward to working alongside other European patient organisations and contributing to future EHA advocacy and collaboration initiatives.